Froment A, Delomez J, Da Nascimento S, Dassonville-Klimpt A, Andrejak C, Peltier F
PLoS One. 2024; 19(9):e0311167.
PMID: 39348373
PMC: 11441642.
DOI: 10.1371/journal.pone.0311167.
Chowdhury R, Safdar N, Ellames D, Ab Ellames D, Wakefield R
Rheumatology (Oxford). 2024; 63(12):e331-e332.
PMID: 38733597
PMC: 11637472.
DOI: 10.1093/rheumatology/keae272.
Kim H, Lee Y, Song M, Kwon B, Kim Y, Lim S
Sci Rep. 2023; 13(1):11275.
PMID: 37438379
PMC: 10338469.
DOI: 10.1038/s41598-023-38394-1.
Edwards B, Mah H, Sabur N, Brode S
J Assoc Med Microbiol Infect Dis Can. 2023; 8(1):64-74.
PMID: 37008589
PMC: 10052910.
DOI: 10.3138/jammi-2022-0029.
Oh C, Menzies D
Clin Exp Pediatr. 2021; 65(5):214-221.
PMID: 34727494
PMC: 9082252.
DOI: 10.3345/cep.2021.01186.
Rifamycin W Analogues from S699 Δ- Strain.
Shi Y, Ye F, Song Y, Zhang X, Lu C, Shen Y
Biomolecules. 2021; 11(7).
PMID: 34206314
PMC: 8301457.
DOI: 10.3390/biom11070920.
8-Deoxy-Rifamycin Derivatives from S699 Strain.
Ye F, Shi Y, Zhao S, Li Z, Wang H, Lu C
Biomolecules. 2020; 10(9).
PMID: 32887371
PMC: 7563148.
DOI: 10.3390/biom10091265.
Drug hypersensitivity in HIV infection.
Peter J, Choshi P, Lehloenya R
Curr Opin Allergy Clin Immunol. 2019; 19(4):272-282.
PMID: 31145192
PMC: 7236403.
DOI: 10.1097/ACI.0000000000000545.
Rifampicin: not always an innocent drug.
Sveroni D, Stefos A, Rigopoulou E, Dalekos G
BMJ Case Rep. 2018; 11(1).
PMID: 30567221
PMC: 6301475.
DOI: 10.1136/bcr-2018-227356.
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
Tweed C, Crook A, Amukoye E, Dawson R, Diacon A, Hanekom M
BMC Infect Dis. 2018; 18(1):317.
PMID: 29996783
PMC: 6042413.
DOI: 10.1186/s12879-018-3230-6.
Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice.
Kim J, Nam W, Kim S, Kwon O, Seung E, Jo J
Int J Mol Sci. 2017; 18(7).
PMID: 28671602
PMC: 5535909.
DOI: 10.3390/ijms18071417.
Treatment of Latent Tuberculosis Infection.
Haley C
Microbiol Spectr. 2017; 5(2).
PMID: 28409555
PMC: 11687480.
DOI: 10.1128/microbiolspec.TNMI7-0039-2016.
Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.
Marjani M, Baghaei P, Kazempour Dizaji M, Gorji Bayani P, Fahimi F, Tabarsi P
Iran J Pharm Res. 2016; 15(1):247-52.
PMID: 27610165
PMC: 4986122.
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M
BMC Infect Dis. 2016; 16(1):453.
PMID: 27567500
PMC: 5002098.
DOI: 10.1186/s12879-016-1790-x.
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid P, Dorman S, Alipanah N, Barry P, Brozek J, Cattamanchi A
Clin Infect Dis. 2016; 63(7):e147-e195.
PMID: 27516382
PMC: 6590850.
DOI: 10.1093/cid/ciw376.
Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.
Wu J, Chiu C, Wei Y, Lai Y
Clinics (Sao Paulo). 2015; 70(6):429-34.
PMID: 26106962
PMC: 4462572.
DOI: 10.6061/clinics/2015(06)08.
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Sterling T, Moro R, Borisov A, Phillips E, Shepherd G, Adkinson N
Clin Infect Dis. 2015; 61(4):527-35.
PMID: 25904367
PMC: 4560029.
DOI: 10.1093/cid/civ323.
Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.
Sanchez-Borges M, Thong B, Blanca M, Ensina L, Gonzalez-Diaz S, Greenberger P
World Allergy Organ J. 2013; 6(1):18.
PMID: 24175948
PMC: 4446643.
DOI: 10.1186/1939-4551-6-18.
Hepatotoxic effects of therapies for tuberculosis.
Senousy B, Belal S, Draganov P
Nat Rev Gastroenterol Hepatol. 2010; 7(10):543-56.
PMID: 20808293
DOI: 10.1038/nrgastro.2010.134.
Current development and future prospects in chemotherapy of tuberculosis.
Nuermberger E, Spigelman M, Yew W
Respirology. 2010; 15(5):764-78.
PMID: 20546189
PMC: 4461445.
DOI: 10.1111/j.1440-1843.2010.01775.x.
